These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 29769534

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
    Wang ZX, Deng TX, Ma Z.
    J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
    [Abstract] [Full Text] [Related]

  • 3. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z, Pan B, Lv S, Ji Z, Wu Q, Lang R, He Q, Zhao X.
    Cell Physiol Biochem; 2018 Oct; 49(2):678-695. PubMed ID: 30165365
    [Abstract] [Full Text] [Related]

  • 4. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
    Dou D, Yang S, Lin Y, Zhang J.
    Cancer Biomark; 2018 Oct; 23(1):79-93. PubMed ID: 29991127
    [Abstract] [Full Text] [Related]

  • 5. Identification of miRNA-Based Signature as a Novel Potential Prognostic Biomarker in Patients with Breast Cancer.
    Tang J, Ma W, Zeng Q, Tan J, Cao K, Luo L.
    Dis Markers; 2019 Oct; 2019():3815952. PubMed ID: 31976020
    [Abstract] [Full Text] [Related]

  • 6. A novel microRNA signature predicts survival in stomach adenocarcinoma.
    Ding B, Gao X, Li H, Liu L, Hao X.
    Oncotarget; 2017 Apr 25; 8(17):28144-28153. PubMed ID: 28423653
    [Abstract] [Full Text] [Related]

  • 7. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
    Wu YS, Lin H, Chen D, Yi Z, Zeng B, Jiang Y, Ren G.
    Gene; 2019 May 20; 697():86-93. PubMed ID: 30779946
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M, Kong X, Wang H, Huang G, Ye C, He Z.
    Oncotarget; 2017 Jan 31; 8(5):8775-8784. PubMed ID: 28060739
    [Abstract] [Full Text] [Related]

  • 10. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT, Guo EN, Liao XW, Chen LS, Wang JL, Ni M, Liang C.
    Oncol Rep; 2018 Oct 31; 40(4):1947-1958. PubMed ID: 30066920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.
    Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. An Integrated miRNA-lncRNA Signature Predicts the Survival of Stage II Colon Cancer.
    Wang XJ, Zeng B, Lin S, Chen M, Chi P.
    Ann Clin Lab Sci; 2019 Nov 05; 49(6):730-739. PubMed ID: 31882423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
    Zhang HM, Yang B, Chen HF, Chi XH, Xi YB, Chen XM, Guo B, He PF, Lu XC.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun 08; 34(6):530-535. PubMed ID: 31032588
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.